A detailed history of Jefferies Financial Group Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 96,750 shares of EXAS stock, worth $5.43 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
96,750
Previous 112,750 14.19%
Holding current value
$5.43 Million
Previous $4.76 Million 38.3%
% of portfolio
0.05%
Previous 0.05%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.43 - $70.83 $678,880 - $1.13 Million
-16,000 Reduced 14.19%
96,750 $6.59 Million
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $1.87 Million - $3.36 Million
45,292 Added 67.14%
112,750 $4.76 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $3.4 Million - $4.46 Million
60,458 Added 863.69%
67,458 $4.66 Million
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $1.94 Million - $2.49 Million
-32,894 Reduced 82.45%
7,000 $517,000
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $838,427 - $1.26 Million
-12,715 Reduced 24.17%
39,894 $2.72 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $708,409 - $1.07 Million
-11,302 Reduced 17.68%
52,609 $4.94 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $1.4 Million - $2.09 Million
29,568 Added 86.1%
63,911 $4.33 Million
Q4 2022

Sep 21, 2023

SELL
$30.35 - $53.15 $797,962 - $1.4 Million
-26,292 Reduced 49.98%
26,317 $1.3 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $1.04 Million - $1.83 Million
34,343 New
34,343 $1.7 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.93B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.